NASDAQ:MBOT - Microbot Medical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.98 +0.01 (+0.51 %) (As of 12/14/2018 04:00 PM ET)Previous Close$1.98Today's Range$1.9056 - $2.0752-Week Range$1.58 - $17.25Volume80,035 shsAverage Volume311,450 shsMarket Capitalization$5.86 millionP/E RatioN/ADividend YieldN/ABeta0.4 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. It also holds an intellectual property portfolio that comprises 9 patent families, which include 9 patents granted in the United States, 12 patents granted outside the United States, and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Receive MBOT News and Ratings via Email Sign-up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MBOT Previous Symbol CUSIPN/A Webwww.microbotmedical.com Phone781-875-3605 Debt Debt-to-Equity RatioN/A Current Ratio12.44 Quick Ratio12.44 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$120,000.00 Price / Sales49.17 Cash FlowN/A Price / Cash FlowN/A Book Value$4.06 per share Price / Book0.49 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-7,580,000.00 Net MarginsN/A Return on Equity-77.99% Return on Assets-73.30% Miscellaneous Employees7 Outstanding Shares2,980,000Market Cap$5.86 million OptionableNot Optionable Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions What is Microbot Medical's stock symbol? Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT." When did Microbot Medical's stock split? How did Microbot Medical's stock split work? Shares of Microbot Medical reverse split before market open on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split. How were Microbot Medical's earnings last quarter? Microbot Medical Inc (NASDAQ:MBOT) issued its earnings results on Wednesday, November, 14th. The biotechnology company reported ($0.58) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.60) by $0.02. View Microbot Medical's Earnings History. When is Microbot Medical's next earnings date? Microbot Medical is scheduled to release their next quarterly earnings announcement on Wednesday, February 13th 2019. View Earnings Estimates for Microbot Medical. What price target have analysts set for MBOT? 1 analysts have issued twelve-month price targets for Microbot Medical's stock. Their forecasts range from $1.75 to $1.75. On average, they expect Microbot Medical's stock price to reach $1.75 in the next twelve months. This suggests that the stock has a possible downside of 11.6%. View Analyst Price Targets for Microbot Medical. What is the consensus analysts' recommendation for Microbot Medical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Microbot Medical. Has Microbot Medical been receiving favorable news coverage? News stories about MBOT stock have trended somewhat positive recently, InfoTrie reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Microbot Medical earned a daily sentiment score of 1.2 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the immediate future. Who are some of Microbot Medical's key competitors? Some companies that are related to Microbot Medical include Titan Pharmaceuticals (TTNP), Vaxart (VXRT), CytRx (CYTR), Windtree Therapeutics (WINT), Mymetics (MYMX), aTyr Pharma (LIFE), TrovaGene (TROV), Genetic Technologies (GENE), Enzon Pharmaceuticals (ENZN), Neuralstem (CUR), Vitro Diagnostics (VODG), Mateon Therapeutics (MATN), Taxus Cardium Pharmaceuticals Group (CRXM), Omni Bio Pharmaceutical (OMBP) and AveXis (AVXS). Who are Microbot Medical's key executives? Microbot Medical's management team includes the folowing people: Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 45)Prof. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 66)Mr. Yoseph Bornstein, Co-Founder & Director (Age 59)Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 49)Mr. Yehezkel Himelfarb, COO, GM of Israeli operations & Director (Age 60) Who are Microbot Medical's major shareholders? Microbot Medical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc (1.27%) and Vanguard Group Inc. (1.27%). Company insiders that own Microbot Medical stock include Leon Lewkowicz, Moshe Shoham, Yoav Zvi Waizer and Yoseph Bornstein. View Institutional Ownership Trends for Microbot Medical. Which institutional investors are selling Microbot Medical stock? MBOT stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc. and Vanguard Group Inc. View Insider Buying and Selling for Microbot Medical. How do I buy shares of Microbot Medical? Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Microbot Medical's stock price today? One share of MBOT stock can currently be purchased for approximately $1.98. How big of a company is Microbot Medical? Microbot Medical has a market capitalization of $5.86 million and generates $120,000.00 in revenue each year. Microbot Medical employs 7 workers across the globe. What is Microbot Medical's official website? The official website for Microbot Medical is http://www.microbotmedical.com. How can I contact Microbot Medical? Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected] MarketBeat Community Rating for Microbot Medical (NASDAQ MBOT)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 249 (Vote Outperform)Underperform Votes: 183 (Vote Underperform)Total Votes: 432MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote "Outperform" if you believe MBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/15/2018 by MarketBeat.com StaffFeatured Article: What strategies should day traders use to execute a trade?